These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 6169352

  • 1. The implications of procainamide metabolism to its induction of lupus.
    Uetrecht JP, Freeman RW, Woosley RL.
    Arthritis Rheum; 1981 Aug; 24(8):994-1003. PubMed ID: 6169352
    [Abstract] [Full Text] [Related]

  • 2. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
    Reidenberg MM, Drayer DE.
    Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
    [Abstract] [Full Text] [Related]

  • 3. Effect of acetylator phenotype on the rate at which procainamide induces antinuclear antibodies and the lupus syndrome.
    Woosley RL, Drayer DE, Reidenberg MM, Nies AS, Carr K, Oates JA.
    N Engl J Med; 1978 May 25; 298(21):1157-9. PubMed ID: 306574
    [Abstract] [Full Text] [Related]

  • 4. Metabolism of procainamide in the perfused rat liver.
    Uetrecht JP, Woosley RL, Freeman RW, Sweetman BJ, Oates JA.
    Drug Metab Dispos; 1981 May 25; 9(3):183-7. PubMed ID: 6166441
    [Abstract] [Full Text] [Related]

  • 5. Procainamide-induced lupus erythematosus-like syndrome in relation to acetylator phenotype and plasma levels of procainamide.
    Sonnhag C, Karlsson E, Hed J.
    Acta Med Scand; 1979 May 25; 206(4):245-51. PubMed ID: 92167
    [Abstract] [Full Text] [Related]

  • 6. Aromatic amines and the pathogenesis of lupus erythematosus.
    Reidenberg MM.
    Am J Med; 1983 Dec 25; 75(6):1037-42. PubMed ID: 6196968
    [Abstract] [Full Text] [Related]

  • 7. Covalent binding of procainamide in vitro and in vivo to hepatic protein in mice.
    Freeman RW, Uetrecht JP, Woosley RL, Oates JA, Harbison RD.
    Drug Metab Dispos; 1981 Dec 25; 9(3):188-92. PubMed ID: 6166442
    [Abstract] [Full Text] [Related]

  • 8. Antibodies to nuclear antigens in patients treated with procainamide or acetylprocainamide.
    Lahita R, Kluger J, Drayer DE, Koffler D, Reidenberg MM.
    N Engl J Med; 1979 Dec 20; 301(25):1382-5. PubMed ID: 91972
    [No Abstract] [Full Text] [Related]

  • 9. Autoallergic reactions induced by procainamide.
    Tan EM, Rubin RL.
    J Allergy Clin Immunol; 1984 Oct 20; 74(4 Pt 2):631-4. PubMed ID: 6386937
    [Abstract] [Full Text] [Related]

  • 10. Thrombocytopenia following sustained-release procainamide.
    Meisner DJ, Carlson RJ, Gottlieb AJ.
    Arch Intern Med; 1985 Apr 20; 145(4):700-2. PubMed ID: 2580499
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Antinuclear antibodies related to acetylator phenotype in mice.
    Tannen RH, Weber WW.
    J Pharmacol Exp Ther; 1980 Jun 20; 213(3):485-90. PubMed ID: 6970809
    [Abstract] [Full Text] [Related]

  • 13. Procainamide, acetylprocainamide, and drug-induced lupus erythematosus.
    Bernstein RE.
    Lancet; 1979 Nov 17; 2(8151):1076. PubMed ID: 91813
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacokinetic studies on the drug-related lupus syndrome. Differences in antinuclear antibody development and drug-induced DNA damage in rapid and slow acetylator animal models.
    Weber WW, Tannen RH.
    Arthritis Rheum; 1981 Aug 17; 24(8):979-86. PubMed ID: 6974557
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical consequences of polymorphic acetylation of basic drugs.
    Drayer DE, Reidenberg MM.
    Clin Pharmacol Ther; 1977 Sep 17; 22(3):251-8. PubMed ID: 19187
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The chemical induction of systemic lupus erythematosus and lupus-like illnesses.
    Reidenberg MM.
    Arthritis Rheum; 1981 Aug 17; 24(8):1004-9. PubMed ID: 6169347
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy, plasma concentrations and adverse effects of a new sustained release procainamide preparation.
    Giardina EG, Fenster PE, Bigger JT, Mayersohn M, Perrier D, Marcus FI.
    Am J Cardiol; 1980 Nov 17; 46(5):855-62. PubMed ID: 6159783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.